Prognostic Scores of Forrest et al for a Patient with Inoperable Non-Small-Cell Carcinoma of the Lung (Glasgow Prognostic Score)

Purpose: To evaluate a patient with an inoprerable non-small-carcinoma of the lung using the Glasgow Prognostic Score of Forrest et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with inoperable non-small-lung carcinoma?

Yes

Serum albumin

Serum C-reactive protein

Select an appropriate answer for each finding

Tumor stage

ECOG performance scale

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total score for CRP and albumin (Glasgow Prognostic score)

Which indicates

Total score for CRP and stage

Total score for CRP and ECOG

Total score for ECOG and stage

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Risk Factors for Lung Cancer
Imaging Studies
- False-Positive & False-Negative Findings for Lung Cancer Associated with Positron Emission Tomography (PET)
Laboratory Tests
- Circulating Tumor Cells (CTC) in Patient with Lung Cancer
- Detection of EGFR Mutation in Non-Small Cell Lung Carcinoma Using Immunohistochemistry (IHC)
Other Testing
- Detection of EGFR Mutation in Non-Small Cell Lung Carcinoma Using Immunohistochemistry (IHC)
Severity, Prognosis, Stage
Complications
- Paraneoplastic Syndromes Seen in Patients with Lung Cancer

Therapy

Options
- Molecular Testing of Lung Adenocarcinoma | EGFR Mutation Testing
Selection
- Small Cell Lung Cancer | Pretreatment Prognostic Score

Specialty

Hematology Oncology
Surgery, general
Pulmonology

Objective

severity
prognosis
stage

ICD-10

C34 - Malignant neoplasm of bronchus and lung

Info

Purpose: To evaluate a patient with an inoprerable non-small-carcinoma of the lung using the Glasgow Prognostic Score of Forrest et al.

Specialty: Hematology Oncology, Surgery, general, Pulmonology

Objective: severity, prognosis, stage

ICD-10: C34,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path